354 related articles for article (PubMed ID: 24077327)
1. Nanoparticle accumulation and transcytosis in brain endothelial cell layers.
Ye D; Raghnaill MN; Bramini M; Mahon E; Åberg C; Salvati A; Dawson KA
Nanoscale; 2013 Nov; 5(22):11153-65. PubMed ID: 24077327
[TBL] [Abstract][Full Text] [Related]
2. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
3. A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers.
Ye D; Dawson KA; Lynch I
Analyst; 2015 Jan; 140(1):83-97. PubMed ID: 25303735
[TBL] [Abstract][Full Text] [Related]
4. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
5. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.
Wiley DT; Webster P; Gale A; Davis ME
Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374
[TBL] [Abstract][Full Text] [Related]
6. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.
Qiao R; Jia Q; Hüwel S; Xia R; Liu T; Gao F; Galla HJ; Gao M
ACS Nano; 2012 Apr; 6(4):3304-10. PubMed ID: 22443607
[TBL] [Abstract][Full Text] [Related]
8. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
9. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
[TBL] [Abstract][Full Text] [Related]
10. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
11. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
12. Gold nanocarriers for transport of oligonucleotides across brain endothelial cells.
Fatima N; Gromnicova R; Loughlin J; Sharrack B; Male D
PLoS One; 2020; 15(9):e0236611. PubMed ID: 32941446
[TBL] [Abstract][Full Text] [Related]
13. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
[TBL] [Abstract][Full Text] [Related]
14. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
15. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model.
Miller F; Fenart L; Landry V; Coisne C; Cecchelli R; Dehouck MP; Buée-Scherrer V
Eur J Neurosci; 2005 Aug; 22(4):835-44. PubMed ID: 16115207
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo methods for assessing FcRn-mediated reverse transcytosis across the blood-brain barrier.
Caram-Salas N; Boileau E; Farrington GK; Garber E; Brunette E; Abulrob A; Stanimirovic D
Methods Mol Biol; 2011; 763():383-401. PubMed ID: 21874466
[TBL] [Abstract][Full Text] [Related]
17. HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.
Dadparvar M; Wagner S; Wien S; Kufleitner J; Worek F; von Briesen H; Kreuter J
Toxicol Lett; 2011 Sep; 206(1):60-6. PubMed ID: 21726608
[TBL] [Abstract][Full Text] [Related]
18. Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability.
Trickler WJ; Lantz SM; Murdock RC; Schrand AM; Robinson BL; Newport GD; Schlager JJ; Oldenburg SJ; Paule MG; Slikker W; Hussain SM; Ali SF
Nanotoxicology; 2011 Dec; 5(4):479-92. PubMed ID: 21175299
[TBL] [Abstract][Full Text] [Related]
19. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
[TBL] [Abstract][Full Text] [Related]
20. A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB).
Yim YS; Choi JS; Kim GT; Kim CH; Shin TH; Kim DG; Cheon J
Chem Commun (Camb); 2012 Jan; 48(1):61-3. PubMed ID: 22057099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
